Most Read Articles
Yesterday
Both denosumab and alendronic acid fall short of reducing disease progression in patients with calcific aortic stenosis, a study has shown.
Roshini Claire Anthony, 4 days ago

Ponesimod, a highly selective sphingosine-1-phosphate receptor 1 modulator, demonstrated superiority over teriflunomide in reducing relapse rate, fatigue, and active lesions in patients with relapsing multiple sclerosis (RMS), results of the phase III OPTIMUM* trial showed.

 

24 Apr 2021
Combination treatment with three or more antihypertensive drugs provides greater blood pressure (BP)-lowering effect than monotherapy, results of a study have shown. However, the net benefit may be lessened when side effects are considered.
01 May 2021
Morbidly obese patients are more likely to have atrial fibrillation and stroke in the presence of obstructive sleep apnoea (OSA), a study suggests.

Expert opinion on maximizing the benefit of bariatric surgery in individuals with increased surgical risk

23 Apr 2021
Bariatric surgery can be a valuable adjunctive approach for selected patients with metabolic syndrome. Patient selection balancing the individual’s benefit: risk profile in terms of long-term benefits of the surgery versus surgical risks is crucial. Modified RSI is a technique used to perform endotracheal intubation which aims to reduce the risk of postsurgical complications and the availability of a reversal agent should be taken into account when modified RSI is considered. 

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Hong Kong digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Yesterday
Both denosumab and alendronic acid fall short of reducing disease progression in patients with calcific aortic stenosis, a study has shown.
Roshini Claire Anthony, 4 days ago

Ponesimod, a highly selective sphingosine-1-phosphate receptor 1 modulator, demonstrated superiority over teriflunomide in reducing relapse rate, fatigue, and active lesions in patients with relapsing multiple sclerosis (RMS), results of the phase III OPTIMUM* trial showed.

 

24 Apr 2021
Combination treatment with three or more antihypertensive drugs provides greater blood pressure (BP)-lowering effect than monotherapy, results of a study have shown. However, the net benefit may be lessened when side effects are considered.
01 May 2021
Morbidly obese patients are more likely to have atrial fibrillation and stroke in the presence of obstructive sleep apnoea (OSA), a study suggests.